top of page

Field Medical Names Mark Turco, MD as Chief Executive Officer

  • Mar 16
  • 1 min read

CARDIFF-BY-THE-SEA, Calif., Mar. 16, 2026 — Field Medical, Inc., a clinical-stage medical technology company advancing second-generation pulsed field ablation (PFA) solutions for complex ventricular and atrial arrhythmias, today announced the appointment of Mark A. Turco, MD, as chief executive officer, effective immediately.


Read the full press release here.


 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.

+1 (980) 412-2298​​​

1910 Palomar Point Way, Suite 101
Carlsbad, CA 92008​​​

​​​​CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.

Follow Us On:

  • LinkedIn
  • X
  • Youtube

Pulsed Field Ablation (PFA) 

Ventricular Tachycardia (VT)

Atrial Fibrillation (AF)

bottom of page